Protecting the Brain: Novel Strategies for Preventing Breast Cancer Brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood–Brain Barrier Models
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25063379 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Janine Kirchner und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Würzburg University, Oberdürrbacher Str. 6, 97080 Würzburg, Germany. Hauptthemen laut MEDLINE: Breast Neoplasms, Brain Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft, Forschung hilft.
Abstract (Originalsprache)
Breast cancer brain metastasis (BCBM) is a challenging condition with limited treatment options and poor prognosis. Understanding the interactions between tumor cells and the blood–brain barrier (BBB) is critical for developing novel therapeutic strategies. One promising target is estrogen receptor β (ERβ), which promotes the expression of key tight junction proteins, sealing the BBB and reducing its permeability. In this study, we investigated the effects of 17β-estradiol (E2) and the selective ERβ agonist diarylpropionitrile (DPN) on endothelial and cancer cells. Western blot analysis revealed the expression patterns of ERs in these cell lines, and estrogen treatment upregulated claudin-5 expression in brain endothelial cells. Using in vitro models of the BBB, we found that DPN treatment significantly increased BBB tightness about suppressed BBB transmigration activity of representative Her2-positive (BT-474) and triple-negative (MDA-MB-231) breast cancer cell lines. However, the efficacy of DPN treatment decreased when cancer cells were pre-differentiated in the presence of E2. Our results support ERβ as a potential target for the prevention and treatment of BCBM and suggest that targeted vector-based approaches may be effective for future preventive and therapeutic implications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anaesthesiology, Intensive Care, Emergency and Pain Medicine, Würzburg University, Oberdürrbacher Str. 6, 97080 Würzburg, Germany.
- Department of Medical Oncology, Fukushima Medical University, 1 Hikarigaoka, Fukushima City 960-1295, Japan.
ORCID-Profile: Sergey Shityakov, Shigehira Saji, Carola Y Förster
Förderung
- Deutsche Forschungsgemeinschaft
- Forschung hilft
Zitieren
APA
Kirchner, J., Völker, E., Shityakov, S., Saji, S., & Förster, C. Y. (2024). Protecting the Brain: Novel Strategies for Preventing Breast Cancer Brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood–Brain Barrier Models. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25063379
Vancouver
Kirchner J, Völker E, Shityakov S, Saji S, Förster CY. Protecting the Brain: Novel Strategies for Preventing Breast Cancer Brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood–Brain Barrier Models. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25063379
BibTeX
@article{Kirchner2024,
author = {Kirchner, Janine and Völker, Elisabeth and Shityakov, Sergey and Saji, Shigehira and Förster, Carola Y},
title = {Protecting the Brain: Novel Strategies for Preventing Breast Cancer Brain Metastases through Selective Estrogen Receptor β Agonists and In Vitro Blood–Brain Barrier Models},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25063379}
}
EUVIMED